Telbivudine and arrhythmia 
Telbivudine and arrhythmia Patient Reports February 11, 2012
Telbivudine Side Effects Report #5815961-3
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 45 years of age, was diagnosed with hepatitis b
, hepatic cirrhosis and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypersplenism, hypoaesthesia, muscular weakness, musculoskeletal pain, myalgia, myopathy, neuralgia. Telbivudine dosage: 600 MG, BID. Patient recovered.Telbivudine Side Effects Report #5815964-9
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 37 years of age, was diagnosed with hepatitis b
and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypoaesthesia, muscular weakness, myalgia, neuralgia. Telbivudine dosage: 600 MG, QD. During the same period patient was treated with INTERFERON. Patient recovered.Telbivudine Side Effects Report #5815993-5
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 35 years of age, was diagnosed with hepatitis b
and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypoaesthesia, muscular weakness, myalgia, neuralgia. Telbivudine dosage: 600 MG, QD. During the same period patient was treated with ADEFOVIR DIPIVOXIL. Patient recovered.Telbivudine Side Effects Report #5815978-9
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 30 years of age, was diagnosed with hepatitis b
and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypoaesthesia, muscular weakness, myalgia, neuralgia. Telbivudine dosage: 600 MG, QD. During the same period patient was treated with INTERFERON. Patient recovered.